CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 192 enrolled
Drug / intervention
Defibrillation of pulseless VT/VF by AECDdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00382928
NCT00382928Phase 1Completed
CompareCT.gov

Automatic External Defibrillation Monitoring in Cardiac Arrest

Foundation for Atlanta Veterans Education and Research, Inc.·interventional·Posted Oct 2, 2006·Updated Jul 15, 2015

In Brief

A Phase 1 clinical trial evaluating Defibrillation of pulseless VT/VF by AECD for Death, Sudden, Cardiac and 2 related conditions. Completed, enrolled 192 participants across 1 site.

Detailed Summary

We propose to randomize automatic external cardioverter/defibrillators (AECD) in patients who are at high risk for life-threatening abnormal heart rhythms (arrhythmias) and are admitted to the telemetry ward, all other treatments being constant including cardiopulmonary resuscitation. We hypothesize that the automatic, rapid, accurate and specific diagnostic and therapeutic technology used in AECDs will further increase the rate of survival in patients with cardiac arrest through rapid and automatic defibrillation, independent of operator initiation, as compared to standard cardiopulmonary resuscitation initiated by healthcare providers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeath, Sudden, Cardiac, Ventricular Fibrillation, Tachycardia, Ventricular
CountriesUnited States
CollaboratorsEmory University

Timeline

Phase 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2, 2006
Enrollment StartOct 1, 2006
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 19.8 years ago

Interventions

Defibrillation of pulseless VT/VF by AECDdevice

In case of cardiac arrest caused by shockable rhythms the automatic external cardioverter defibrillator (AECD) will automatically deliver defibrillation. Automated External Cardioverter Defibrillator (AECD; The PowerHeart CRM, Cardiac Science Inc., Seattle, WA) is a device attached to the chest wall by pads, monitors the electrocardiogram, and is capable of automatically delivering electric countershock to appropriate rhythms without operator intervention. The device will deliver only one shock of 150 Joules for pulseless ventricular tachycardia and ventricular fibrillation.